Study details
Enrolling now
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
CivaTech Oncology
NCT IDNCT02843945ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
80
Study length
about 11 years
Ages
18+
Locations
6 sites in FL, IL, LA +2
What this study is about
This trial is testing a new treatment for borderline resectable pancreatic cancer. It involves implanting a device called a CivaSheet at the time of surgery, if there are close or positive margins around the tumor. The goal is to see if this method helps control the cancer locally.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Directional Brachytherapy Source Implant
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Length of Hospital Stay
Devices
implantable
Body systems
Oncology